Pharmafile Logo
Pharmafocus logo
Advanced Search

High Force Research appoints Nathalie Huther as chief commercial officer

April 8, 2025
Manufacturing and Production, Research and Development Corporate, High Force Research, cco, manufacturing and production

High Force Research has announced that it has appointed Nathalie Huther as its first chief commercial officer (CCO) following the …

Appointment

ELRIG appoints Del Trezise as chair

April 8, 2025
Research and Development ELRIG, Pharmacy, R&D, drug discovery, non-profit organisation, pharma

ELRIG, a non-profit volunteer-led organisation dedicated to the drug discovery community, has appointed Del Trezise as chair of the board. …

Appointment

Academy of Medical Sciences invests record £7.6m into early-career biomedical researchers

April 7, 2025
Research and Development Academy of Medical Sciences, British Heart Foundation, Corporate, Wellcome, biomedical research, funding

The Academy of Medical Sciences has awarded £7.6m to support 62 early-career biomedical researchers across the UK, marking the largest …

News

European consortium launches project to advance alpha-emitting radiotherapies

April 7, 2025
Research and Development Akiram Therapeutics, European Consortium, Oncology, PreTT, TetraKit Technologies, radiotherapy

A new European research initiative PRE-CISE has been launched with the aim of developing next-generation targeted alpha-therapies for cancer treatment. …

News

New hormonal treatment launched to help prevent miscarriage in early pregnancy

April 4, 2025
Research and Development Besins Healthcare, Reproductive health, hormonal therapy, miscarriage, pregnancy

A new progesterone-based treatment aimed at preventing miscarriage has been launched across the UK, following a major clinical trial that …

News

Mehiläinen acquires Regina Maria and MediGroup, and welcomes Hellman & Friedman as new shareholder

April 4, 2025
Business Services, Marketing Services CVC, Corporate, MediGroup, Mehilainen, Regina Maria, shareholders

Mehiläinen, a Finnish health and social care provider, has announced that it has agreed to acquire Regina Maria and MediGroup. …

News

Bristol Myers Squibb receives positive CHMP opinion for Opdivo treatment

April 4, 2025
Research and Development CHMP, Oncology, bristol myers squibb, immunotherapy, lung cancer, opdivo

Bristol Myers Squibb (BMS) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for …

News
handshake_2

Curium Pharma announces acquisition of Monrol

April 3, 2025
Manufacturing and Production, Research and Development Curium Pharma, Monrol, Oncology, acquisition, nuclear medicine, radiopharmaceutical products

Curium Pharma, a nuclear medicine company, has acquired Eczacıbaşı-Monrol Nuclear Products (Monrol), a nuclear medicine player. With facilities across Europe …

News

Enosium Life Science acquires RWEality

April 3, 2025
Business Services, Consultancy Consultancy, Corporate, Enosium Life Sciences, RWEality, acquisition, life sciences, research and development

Enosium Life Science, which specialises in life sciences, has acquired RWEality, a consultancy focused on public policies, technology and healthcare …

News

Bend Bioscience adds commercial spray drying facility to Georgia site

April 3, 2025
Manufacturing Services, Manufacturing and Production Bend Bioscience, CDMO, Devices, manufacturing, pharma

Bend Bioscience has announced the addition of a commercial-scale spray dryer and a Gerteis dry granulation system at its facility …

News

GRI Bio announces two global patents granted for Europe and Japan

April 2, 2025
Research and Development Chronic Diseases, GRI Bio, autoimmune diseases, biotech, fibrotic diseases, inflammatory diseases, patent

GRI Bio, a biotech company that specialises in treatment for inflammatory, fibrotic and autoimmune diseases, has announced that two global …

News

Usama Dar appointed as chief product and technology officer at CluePoints

April 2, 2025
Research and Development Pharmacy, clinical trial analysis, cluepoints, pharma, research and development

CluePoints has appointed Usama Dar as its new chief product and technology officer, effective 1 April 2025. This follows Dar’s …

Appointment

Dupixent approved as first biologic medicine in Japan for COPD patients

April 2, 2025
Research and Development COPD, Chronic Diseases, Regeneron, Sanofi, biotech, respiratory disease

The Ministry of Health, Labour and Welfare in Japan has authorised marketing and manufacturing of Dupixent (dupilumab) for the treatment …

News
biology-think-networking-physiology-brain-anatomy-2676370

ADHD coach and breathwork experts to run workshop for ADHD management

April 2, 2025
Design & Creative, Freelancers ADHD, Neurology, healthcare, mental health, nervous system

ADHD coach John Harrington and breathwork facilitator Martin O’Toole will collaborate on ‘Breathwork for ADHD and Beyond’, a breathwork-orientated session …

News

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

April 1, 2025
Research and Development Cardiology, Novo Nordisk, cardiometabolic diseases, research and development

Novo Nordisk announced results from its SOUL cardiovascular outcomes trial. Rybelsus (oral semaglutide) significantly reduced the risk of major adverse …

News

Corcept’s relacorilant trial in patients with platinum-resistant ovarian cancer meets primary endpoint

April 1, 2025
Research and Development Corcept Therapeutics, Oncology, ovarian cancer, research and development

Corcept Therapeutics announced that relacorilant plus nab-paclitaxel met its primary endpoint of improved progression-free survival in ROSELLA, the company’s phase …

News

Secarna Pharmaceuticals to announce positive new data at cancer research conference

April 1, 2025
Research and Development Oncology, Secarna Pharmaceuticals, oncology, research and development

Secarna Pharmaceuticals will present new preclinical data with its lead programme SECN-15 at the American Association for Cancer Research (AACR) …

News

Qfitlia approved by FDA to treat haemophilia A or B

March 31, 2025
Research and Development FDA, Haematology, Sanofi, haemophilia, pharma

The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran) as the first therapy in the US to treat …

News

Alfred Merz appointed as CEO of ProBioGen

March 31, 2025
Manufacturing Services, Manufacturing and Production CEO, Pharmacy, ProBioGen, appointment, biotech

ProBioGen has announced the appointment of Alfred Merz as its chief executive officer (CEO), effective 1 April 2025. Merz, who …

Appointment
hsm_mobile_clinical_trial_istock-872676342

Medidata launches programme to accelerate therapy delivery

March 31, 2025
Market Research Medidata, Pharmacy, pharma, technology

Medidata has announced the launch of its Medidata Site Insights Program – a collection of initiatives intended to foster more …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026